Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print How HIV cripples immune cells

How HIV cripples immune cells

September 17, 2009

In order to be able to ward off disease pathogens, immune cells must be mobile and be able to establish contact with each other. The working group around Professor Dr. Oliver Fackler in the Virology Department of the Hygiene Institute of the Heidelberg University Hospital has discovered a mechanism in an animal model revealing how HIV, the AIDS pathogen, cripples immune cells: Cell mobility is inhibited by the HIV Nef protein. The study was published in the highly respected journal "Cell Host & Microbe". This discovery may have pointed the way towards a new treatment approach.

Over 30 million persons worldwide are infected with HIV. Typically, after the initial infection accompanied by acute symptoms, there is a latency period of several years before the acquired immune deficiency syndrome (AIDS) manifests. The human immunodeficiency virus (HIV) has developed numerous strategies for eluding the body's defenses and the medications administered. The prerequisite for efficient reproduction of the virus in the patient's body is the virus's own Nef protein. Without Nef, the development of AIDS is significantly slowed or even stopped completely. The underlying mechanism of this observation was a complete mystery up to now, however.




HIV modifies the cell structure system of the host cells

Viruses alter the support structures of affected cells, enabling them to enter the cells more easily. The cell structure element actin, which also gives muscles their mobility, aids in the motility of immune cells. This is necessary for immune cells to be able to establish contact with each other and combat the virus. After each movement, actin must be returned to its original state in order to be available once again. HIV especially attacks immune cells of the T-helper type. These cells support not only direct "defense against the enemy", but are also necessary for building sufficient antibodies against the invader. For this, they must rely on their mobility.

Short-circuiting of two different signal paths in the cell by Nef

The researchers examined the movement of cells in living zebra fish embryos and were able to show that cell mobility is inhibited by the HIV Nef protein. As they continued their experiments on cell cultures, they were able to explain the underlying mechanism: Nef causes an enzyme that normally has nothing to do with cell mobility to deactivate a regulator for actin regeneration. Nef therefore causes a short-circuit of two cellular mechanisms, thus inhibiting the reorganization of the cell structure element actin and the cell's ability to move. Thus, the affected immune cells can no longer fulfill their function.

"We speculate that the negative effect of Nef on the mobility of T-helper cells has far reaching consequences for the efficient formation of antibodies by B-lymphocytes in the patient. The mechanism we have described could be involved in the increasingly observed malfunction of B-lymphocytes in AIDS patients", explains Professor Fackler. Up to now, Nef has not been a target of antiviral therapy. Since one of the first molecular mechanisms has now been decoded, however, and the importance of Nef for the disease has become clearer, this could change in the future.



Heidelberg University Hospital



Related HIV Current Events and HIV News Articles HIV Current Events and HIV News RSS HIV Current Events and HIV News RSS
Many pregnant women avoid HIV screening in Africa
'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission.

An atomic-level look at an HIV accomplice
Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity.

New findings suggest strategy to help generate HIV-neutralizing antibodies
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria
A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease.

No-entry zones for AIDS virus
The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.

Hoping for a fluorescent basket case
Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem.

Scientists explain binding action of 2 key HIV antibodies; could lead to new vaccine design
A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine.

U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat
Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.

1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.

Indiana U. at APHA: Studies about why men and women use lubricants during sex
An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex.
More HIV Current Events and HIV News Articles
100 Questions and Answers About HIV and AIDS

100 Questions and Answers About HIV and AIDS
by Joel Gallant (Author)



The First Year: HIV: An Essential Guide for the Newly Diagnosed (First Year, The)

The First Year: HIV: An Essential Guide for the Newly Diagnosed (First Year, The)
by Brett Grodeck (Author), M.D. Daniel S. Berger (Foreword)

This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African Americans.

HIV Essentials 2010

HIV Essentials 2010
by Paul E. Sax (Author), Calvin J. Cohen (Author), Daniel R. Kuritzkes (Author)

HIV Essentials 2010 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management and prevention of HIV infection and its complications. Topics include: HIV diagnosis, evaluation, treatment and prevention; Opportunistic infections and other HIV Complications; Treatment of HIV and pregnancy; Antiretroviral drug summaries; Post-exposure Prophylaxis; New section to each drug summary called "How Supplied" describes the commercially available dosage forms for all the ARV's

Home Access HIV - 1 Express Test System - 1 ea

Home Access HIV - 1 Express Test System - 1 ea
by Home Access

Next Day Results*
Contains one single-use sample collection kit

Living with HIV: A Patient's Guide

Living with HIV: A Patient's Guide
by Mark Cichocki (Author)

This helpful guide offers a wealth of information for individuals who have been diagnosed with HIV and for people caring for HIV positive friends and loved ones. It covers the entire HIV lifespan, from prevention to diagnosis and beyond. Valuable tips help the reader make the best decision when choosing a doctor, finding and adhering to the right medication regimen, and, if necessary, making end-of-life plans. All aspects of HIV/AIDS are discussed, including opportunistic and associated infections, dental care, exercise and nutrition, substance use and abuse, and emotional treatment.

The Naked Truth: Young, Beautiful, and (HIV) Positive

The Naked Truth: Young, Beautiful, and (HIV) Positive
by Marvelyn Brown (Author), Courtney Martin (Author)

The surprisingly hopeful story of how a straight, nonpromiscuous, everyday girl contracted HIV and how she manages to stay upbeat, inspired, and more positive about life than ever before

At nineteen years of age, Marvelyn Brown was lying in a stark white hospital bed at Tennessee Christian Medical Center, feeling hopeless. A former top track and basketball athlete, she was in the best shape of her life, but she was battling a sudden illness in the intensive care unit. Doctors had no idea what was going on. It never occurred to Brown that she might be HIV positive.

Having unprotected sex with her Prince Charming had set into swift motion a set of circumstances that not only landed her in the fight of her life, but also alienated her from her community. Rather than give...

Absolutely Positive

Absolutely Positive
Directed By: Peter Adair
Also With: Janet Cole (Cinematographer), Peter Adair (Cinematographer), Peter Adair (Writer)

Ten years following its ground-breaking debut at Sundance, the landmark film that first humanized the face of AIDS is now available in this special 10th Anniversary Edition. Simultaneously heart-wrenching and life affirming, ABSOLUTELY POSITIVE is an hon

HIV and the Pathogenesis of AIDS, 3rd Edition

HIV and the Pathogenesis of AIDS, 3rd Edition
by Jay A. Levy (Author)

The new edition of HIV and the Pathogenesis of AIDS provides a state-of-the-art review of the current research, explains the history of the disease, and examines how scientists, clinicians, and public health workers have responded to the challenges presented by HIV/AIDS in the 25 years since its recognition. Many exciting developments in the field have deepened scientific understanding of HIV/AIDS and have provided novel approaches for prevention and treatment. The book explores potential approaches for therapy and a vaccine for the prevention of HIV infection and AIDS is discussed.

Thoroughly updated and revised, the third edition continues to provide a comprehensive analysis of the subject that is unmatched in the field. Figures and tables illustrate and emphasize key points and...

HIV/AIDS: A Very Short Introduction (Very Short Introductions)

HIV/AIDS: A Very Short Introduction (Very Short Introductions)
by Alan Whiteside (Author)

HIV/AIDS is without doubt the worst epidemic to hit humankind since the Black Death. As of 2004 an estimated 40 million people were living with the disease, and about 20 million had died. Despite rapid scientific advances there is still no cure and the drugs are expensive and toxic. In the developing world, especially in parts of Africa, life expectancy has plummeted to below 35 years, causing a serious decline in economic growth, a sharp increase in orphans, and the imminent collapse of health care systems. The news is not all bleak though. There have been unprecedented breakthroughs in understanding diseases and developing drugs. Because the disease is so closely linked to sexual activity and drug use, the need to understand and change behavior has caused us to reassess what it means...

HIV GIANT MICROBE

HIV GIANT MICROBE
by Giant Microbes

H.I.V. kills CD4 cells, or T-helper cells ? Once the immune system is compromised, a person develops AIDS (acquired immuno-deficiency syndrome) ? H.I.V. is most commonly transmitted by sexual contact with an infected person

? Insect bites and sweat carry almost no risk of transmission ? Studies show that drying H.I.V. infected fluids can reduce viral presence by 90-99% ? There is no vaccine for H.I.V. and no cure for AIDS

© 2009 BrightSurf.com